1. Introduction {#s0005}
===============

In healthy individuals, the internal tissues are devoid of pathogens, whereas the external tissues like oral cavity are exposed to various kinds of microorganisms ([@b0250]). The oral cavity is the starting point of the gastrointestinal tract. Because of the frequent supply of food through oral cavity, it creates a favourable environment for nurturing and harbouring microorganisms. The surfaces of oral cavity are covered with diverse microorganisms, constructing the proverbial bacterial biofilm and maintain a dynamic ecological balance with the host body. Any disruption in this equilibrium causes oral disease ([@b0170]). In healthy oral cavity, there is a distinctive predominant bacterial flora that are not only highly diverse in nature but also subject and site-specific ([@b0005]). There are numerous microorganisms that come under the broader term oral microflora and include bacteria, fungi, most protozoa but rarely viruses. The diversity and counts of microflora vary according to food habits, salivary features and antibiotic regimens used for treating infections ([@b0105]). Oral bacteria have been associated in the pathogenesis of highly prevalent oral diseases such as dental caries ([@b0150], [@b0030], [@b0015]) and periodontal disease ([@b0055], [@b0075]). A clear understanding about the molecular diversity of microflora is important for pre-emption and redemption of associated health conditions. The phenotypic methods of bacterial identification based on microscopy and culture techniques are less sensitive, subjective and time consuming ([@b0215]). On the other hand, polymerase chain reaction (PCR) provides the highest sensitivity for the detection of microorganisms ([@b0190]).

It is important to note that oral bacteria associated with periodontal disease are mainly anaerobic and therefore they are very difficult to cultivate ([@b0040]). Genotyping of microorganisms using 16S rRNA gene sequencing has been recognized as a more sensitive, specific and accurate method for bacterial identification ([@b0050]). By virtue of the well-conserved regions in 16S rRNA gene among different biological species, comparison of these sequences provides a useful tool for studying molecular diversity and evolutionary phylogenetics ([@b0205]). [@b0175] have shown that 16S rRNA gene is highly useful for detection of culture-negative bacteria in patients pre-treated with antibiotic drugs. Molecular methods for species specific identification of oral bacteria can be based on sequence-specific primers ([@b0125]), probes ([@b0185]) or direct sequencing ([@b0110], [@b0180]).

Several studies have reported significantly high prevalence of periodontitis ([@b0100], [@b0105]) and dental caries ([@b0020], [@b0245]) in adults, children, and older population of Saudi Arabia. Moreover, putative role of specific oral bacterial species has also been suggested in many systemic diseases, including diabetes ([@b0225], [@b0195]) and cardiovascular disease ([@b0200], [@b0220]). Poor oral health may adversely affect diabetic glycemic control and subsequent medical complications ([@b0155]). The biofilm built in the oral cavity has been associated with health and disease ([@b0250]). The bacterial diversity of the oral biofilm is variable among individuals and influences by several factors including age, diet, oral hygiene and genetics ([@b0145]). The diversity and pattern of bacterial exposure in early life of an individual play an important role in the gut colonization of bacteria ([@b0010]). A reduced bacterial diversity in the gut has been found to correlate with higher risks of chronic diseases like allergy and asthma ([@b0070]).

Although the implication of molecular methods for identification and diversity analysis of oral microflora is of great concern, there are very few studies undertaken in Saudi Arabia in this particular field. The aim of this study was to compare the diversity of common dental bacteria in non-diabetic and diabetic patients, using the sequence-specific primers. This study is focused on 5 species of periodontal pathogenic bacteria including *Porphyromonas gingivalis* (*P. gingivalis*), *Tannerella forsythia* (*T. forsythia*), *Capnocytophaga ochracea* (*C. ochracea*), *Prevotella intermedia* (*P. intermedia)* and *Aggregatibacter actinomycetemcomitans* (*A. actinomycetemcomitans*).

2. Materials and methods {#s0010}
========================

2.1. Subjects and study design {#s0015}
------------------------------

This study was conducted on 28 unrelated Saudi Arabian female subjects. One group included 14 type-2 diabetic patients with periodontal disease recruited consecutively from Clinic of Dentistry, Section of periodontology, King Saud University, Riyadh, Saudi Arabia. The other group composed of 14 healthy non-diabetic subjects, this group served as control group. All subjects gave an informed written consent before the study, answered a set of questionnaire and underwent clinical and physical examinations. Periodontal examinations were carried out by qualified dentists.

The inclusion criteria were female gender, residents of Riyadh, age range 18--70 years, presence of \> 20 intact natural teeth, features of periodontitis (loss of attachment ≥ 5 mm), and type-2 diabetes. The exclusion criteria were the use of antibiotic therapy during the last 2 months and presence of any systemic disease that may influence the periodontal condition. The study protocol was approved by the Research Ethics Committee of the Faculty of Science, King Saud University, Riyadh, Saudi Arabia.

2.2. Sample collection and bacterial lysis {#s0020}
------------------------------------------

The subgingival samples were collected from four sites (about 5 mm depth) from tooth pockets by a professional dentist in the morning time, using separate sterile paper points (size 40, taper 0.04) from META Company, South Korea. A single vertical stroke was used under quality control procedures for each member of case and control group. All the samples were promptly kept in individual sterile Eppendorf tubes containing Tris-EDTA buffer (pH 7.6). For PCR amplification, 10 μl of lysis buffer was mixed with 90 μl of subgingival sample and the solution was boiled for 5 min. An aliquot of the lysate (4 μl) was used for PCR amplification of each sample.

2.3. Bacterial identification by PCR {#s0025}
------------------------------------

PCR detection for all target bacteria was performed using species specific primers. The primers for the 16S ribosomal DNA sequences were selected and purchased from Eurofins Genomics, Germany**.** The primer pairs used for the PCR amplification and the expected product sizes are given in [Table 1](#t0005){ref-type="table"}.Table 1Sequences of PCR primers.Oral bacteriaPrimer sequenceProduct size (bp)*P. gingivalis*TGT AGA TGA CTG ATG GTG AAA ACC197ACG TCA TCC CCA CCT TCC TC*T. forsythia*GCG TAT GTA ACC TGC CCG CA641TCG TTC AGT GTC AGT TAT ACC T*C. ochracea*AGA GTT TGA TCC TGG CTC AG185GAT GCC GTC CCT ATA TAC CAT TAG G*P. intermedia*TTT GTT GGG GAG TAA AGC GGG575TCA ACA TCT CTG TAT CCT GCG T*A. actinomycetemcomitans*AGA GTT TGA TCC TGG CTC AG\
CAC TTA AAG GTC CGC CTA CGT GCC593

The PCR was carried out in a total volume of 30 μl containing 26 μl of reaction mixture and 4 μl of the lysate sample. The reaction mixture contained 1x PCR buffer (10 mM Tris-HCl pH 8.8, 1.5 mM MgCl~2~, 50 mM KCl, 0.1% Triton X-100), 2 units of Taq DNA polymerase, 0.2 mM dNTPs and 100 pmol of each primer. The cycling conditions were programmed as an initial denaturation step at 95 °C for 5 min followed by the 35 amplification cycles of denaturation at 95 °C for 1 min, primers annealing at 60 °C for 1 min and primer extension at 72 °C for 1.5 min. After completion of all the cycles, a final extension step at 72 °C for 7 min was programmed, followed by storing the tubes at 4 °C. PCR was carried out in a thermal cycler (Applied Biosystems, USA) as reported earlier ([@b0125]).

2.4. Statistics {#s0030}
---------------

The frequency of dental bacteria between the control and diabetic groups was analysed by Fisher's exact test using the CalcFisher program ([@b0120]). P values \< 0.05 were considered as statistically significant.

3. Results {#s0035}
==========

PCR-based identification of dental bacteria using sequences specific primers for each target species resulted intense gel bands of anticipated sizes as follows: *P. gingivalis* (197 bp), *T. forsythia* (641 bp), *C. ochracea* (185 bp), *P. intermedia* (575 bp), and *A. actinomycetemcomitans* (593 bp) ([Fig. 1](#f0005){ref-type="fig"}). The diversity and frequency of dental bacteria among 14 clinically healthy control subjects and 14 diabetic patients are shown in [Table 1](#t0005){ref-type="table"}. In control subjects, the prevalence of *P. gingivalis*, *T. forsythia*, *C. ochracea*, and *P. intermedia* was 35.7%, 14%, 28.5% and 14% respectively, whereas *A. actinomycetemcomitans* was completely absent in this group. In diabetic patients, *C. ochracea* appeared to be highly prevalent (100%) followed by *P. gingivalis* (43%), *A. actinomycetemcomitans* (43%), *P. intermedia* (35.7%) and T. forsythia (28.5%).Fig. 1Representative gel images showing the specific bands for different bacteria. Abbreviations are Pg, *P. gingivalis*; Tf, *T. forsythia*; Co, *C. ochracea*; Pi, *P. intermedia*; Aa, *A. actinomycetemcomitans*.

There were positive amplifications for *P. gingivalis* in 5 out of 14 (35%) healthy subjects and in 6 out of 14 (43%) diabetic samples. PCR amplification using sequences specific primers for *T. forsythia* resulted intense gel bands in only 2 out of 14 (14%) control samples and 4 out of 14 (28.5%) diabetic samples. PCR analysis using 16S rDNA primers confirmed the presence of *C. ochracea* in all subgingival samples from diabetic patients (100%) while only 4 out of 14 (28.5%) control subjects showed the presence of this bacterial species ([Table 1](#t0005){ref-type="table"}). *P. intermedia* were detected in 2 of the 14 control subjects (14%) as compared to 5 of 14 (35.7%) in diabetic group. None of the control subjects showed the occurrence of *A. actinomycetemcomitans* in their subgingival samples whereas 6 of the 14 diabetic patients (42.8%) were found to be positive for *A. actinomycetemcomitans* ([Table 1](#t0005){ref-type="table"}). The statistical analysis showed significantly higher (P \< 0.05) prevalence of *C. ochracea* and *A. actinomycetemcomitans* in diabetic patients as compared to control subjects ([Fig. 2](#f0010){ref-type="fig"}).Fig. 2Comparative prevalence of dental bacteria in controls and diabetic patients. \*P \< 0.05 versus control group using Fisher's exact test. Abbreviations are Pg, *P. gingivalis*; Tf, *T. forsythia*; Co, *C. ochracea*; Pi, *P. intermedia*; Aa, *A. actinomycetemcomitans*.

4. Discussion {#s0040}
=============

The results of this study showed that the occurrence of dental bacteria was more prevalent in subgingival samples from diabetic patients as compared to control subjects ([Table 2](#t0010){ref-type="table"}). Oral bacteria are known to predominantly colonize on different surfaces in oral cavity with the aid of specific adhesins located on the bacterial wall that specifically bind to complementary receptors found on the oral surfaces ([@b0080]). Based on the 16S rDNA sequence data generated from human subgingival plaque samples, the dominant microflora included 347 species that fell into 9 bacterial phyla, while multiple subjects showed the presence of known putative oral bacteria including *P. gingivalis*, *B. forsythus*, and *T. denticola* ([@b0165]). [@b0140] have reported variable trends of 40 cultivable bacteria on the surfaces of oral tissue, gingival plaques and saliva from healthy individuals. In fact, all the patients with periodontal disease do not necessarily harbour the similar subgingival microorganisms, hence, only a limited number of oral bacteria have been suggested as the predictors for the progression of periodontal damage ([@b0235]).Table 2Distribution of oral bacteria in healthy subjects and diabetic patients.SNOral bacteriaControlDiabetesP-Value1*P. gingivalis*5 (35.7%)6 (43.0%)0.7202*T. forsythia*2 (14.0%)4 (28.5%)0.4063*C. ochracea*4 (28.5%)14 (100%)0.000074*P. intermedia*2 (14.0%)5 (35.7%)0.2305*A. actinomycetemcomitans*0 (0.0%)6 (43.0%)0.0079

The prevalence of two bacterial species, *Capnocytophaga ochracea* and *Aggregatibacter actinomycetemcomitans*, was significantly higher in diabetic patients as compared to normal subjects ([Fig. 2](#f0010){ref-type="fig"}). *Capnocytophaga* is a gram-negative bacterium that has been linked in the pathogenesis of periodontal disease ([@b0115]). These microorganisms are able to produce various enzymes with the tendency to periodontal breakdown and therefore considered as opportunistic pathogens. Their high frequency in diabetic group may be attributed to the anaerobic conditions of the subgingival pocket due to high glucose levels that would cause excessive periodontal damage in diabetic patients ([@b0135]). An interesting observation is that all the diabetic patients harboured *C. ochracea* whereas only 4 out of 14 control subjects showed the presence of *C. ochracea* anaerobes in their sub-gingival pockets ([Fig. 2](#f0010){ref-type="fig"}). These results are in agreement with an earlier study reporting that *Capnocytophaga* species are frequently isolated in adult periodontitis subjects while their frequency and counts are significantly higher in the diseased sites of diabetic as compared to non-diabetic periodontitis patients ([@b0045]).

None of the control subjects showed the presence of *A. actinomycetemcomitans* in their subgingival pockets whereas 43% of diabetic patients harboured this pathogen. *A. actinomycetemcomitans* has a vital role in the initiation of periodontal disease and if not treated properly, tooth turns to be mobile and severely damaged because of the progressive bone and attachment loss leading to ultimate tooth extraction ([@b0210], [@b0095]). Interestingly, *A. actinomycetemcomitans* can migrate to and colonize in the heart tissue and has been suggested as a risk factor in the development of cardiac disease ([@b0085], [@b0230])*.* Hence, timely detection of *A. actinomycetemcomitans* in oral samples would have a greater impact on health issues extending beyond the denture. Our results are consistent with previous reports that demonstrated high prevalence of *A. actinomycetemcomitans* in patients with diabetes mellitus ([@b0160])*.* In our study, subgingival samples from 28.5% of diabetic patients were *T. forsythia* positive as compared to 14% healthy controls. *T. forsythia* bacterium is an anaerobic, Gram-negative species of *Cytophaga Bacteroidetes* family, linked with the development of periodontal disease ([@b0035]). [@b0060] failed to observe any association between *T. forsythia* and periodontal status whereas the occurrence of *P. gingivalis* and *A. actinomycetemcomitans* was independently and significantly associated with chronic periodontitis.

In conclusion, the findings of this study showed that dental bacteria are more prevalent in diabetic patients than non-diabetic subjects. Particularly, the prevalence of *C. ochracea* and *A. actinomycetemcomitans* was significantly higher in diabetic patients as compared to healthy individuals. Further studies with larger sample size should be conducted to confirm a more detailed description of bacterial species associated with oral disease in diabetic patients which can throw light on a variety of etiological microorganisms. Recent studies have advocated that patients with periodontal disease are more susceptible to metabolic syndrome ([@b0130], [@b0065]). Severe periodontal disease may also put diabetic patients at increased risk of diabetic complications ([@b0240]). For a long time, it was thought that bacteria were the causative factors for the association between periodontal disease and systemic disease. However, recent researches have demonstrated that inflammation caused by bacterial invasion may be responsible for such association ([@b0090], [@b0025]). Efforts should be made to focus on treating the inflammation besides targeting periodontal bacteria for more efficient management of oral disease.
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